Smyrna, Georgia Clinical Trials

A listing of Smyrna, Georgia clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19

This randomized, open-label, prospective, parallel-group controlled clinical study that aims to explore the natural history of COVID-19 illness and the safety of KB109, a novel glycan, plus SSC versus SSC alone and measures of health in outpatients with mild-to-moderate COVID-19.

Mount Vernon Clinical Research
 (7.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +7 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
tirzepatide
dulaglutide
body mass index
Atlanta Diabetes Associates
 (6.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

non-squamous non-small cell lung cancer
neutrophil count
immunohistochemistry
multicentric castleman disease
stage iia lung cancer ajcc v7
Northside Hospital
 (7.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

measurable disease
neutrophil count
cataract
schwartz
nf2 gene
Children's HealthCare of Atlanta (Site 950)
 (9.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +16 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

shortness of breath
regurgitation
aortic valve replacement
fatigue
Piedmont Healthcare
 (9.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.

fibroscan
fatty liver
hepatic fibrosis
fibrosis
vcte
Gastrointestinal Specialists of Georgia
 (5.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer

The BESPOKE CRC study will prospectively enroll patients who have undergone surgery for stage II or III colorectal cancer (CRC) and who have residual formalin-fixed paraffin-embedded (FFPE) tissue available will provide FFPE and whole blood samples. Patients will receive SIGNATERA test results and may be recommended for adjuvant chemotherapy or …

formalin-fixed paraffin-embedded
adenocarcinoma of the colon
adenocarcinoma
adenocarcinoma of colon
adjuvant chemotherapy
Piedmont Cancer Institute, PC
 (6.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +16 other locations
Description of Patients With Type 1 Diabetes Treated With Teplizumab (TEPLI-REAL)

Type 1 diabetes mellitus (T1D) is a chronic autoimmune disease caused by the destruction of pancreatic β cells. T1D pathogenesis progresses through several stages: Stage 1 T1D includes the presence of β cell autoimmunity and thus presence of islet autoantibodies, without the presence of dysglycemia and symptoms. Stage 2 T1D …

Atlanta Diabetes Associates
 (6.6 away) Contact site
  • 0 views
  • 15 May, 2025
  • +1 other locations